Invesaro

Stocks Comparison

McKesson vs NU Skin Enterprises: revenue, profit, margins and growth compared

McKesson brought in $403.4B of revenue in fiscal 2026, NU Skin Enterprises $1.5B in fiscal 2025. Revenue changed by +12.4% at McKesson and -14.3% at NU Skin Enterprises on the year before, so McKesson grew faster. McKesson kept 1.2% of its revenue as net profit, NU Skin Enterprises 10.8%. Free cash flow was $5.7B at McKesson and $46M at NU Skin Enterprises.

Side by side, latest fiscal year

MCKNUS
Fiscal year endedFY2026 (March 31, 2026)FY2025 (December 31, 2025)
Revenue$403.4B$1.5B
Revenue growth+12.4%-14.3%
Net income$4.8B$160.2M
Net margin1.2%10.8%
Free cash flow$5.7B$46M
Free cash flow margin1.4%3.1%
Earnings per share (diluted)$38.38$3.18
Cash$4B$238.6M
Debt$6.5B$224.2M
Price to earnings22.61.5
Market value$101B$225.4M
Dividend yield0.37%n/a
Rank by revenue in sector#2 of 523 · Health care#122 of 523 · Health care

Over the years

Revenue
MCK FY2019: $214.3BMCK FY2020: $231.1BMCK FY2021: $238.2BMCK FY2022: $264BMCK FY2023: $276.7BMCK FY2024: $309BMCK FY2025: $359.1BMCK FY2026: $403.4BNUS FY2018: $2.7BNUS FY2019: $2.4BNUS FY2020: $2.6BNUS FY2021: $2.7BNUS FY2022: $2.2BNUS FY2023: $2BNUS FY2024: $1.7BNUS FY2025: $1.5BFY18FY19FY20FY21FY22FY23FY24FY25FY26
MCK $403.4BNUS $1.5B
Net income
MCK FY2019: $34MMCK FY2020: $900MMCK FY2021: -$4.5BMCK FY2022: $1.1BMCK FY2023: $3.6BMCK FY2024: $3BMCK FY2025: $3.3BMCK FY2026: $4.8BNUS FY2018: $121.9MNUS FY2019: $173.6MNUS FY2020: $191.4MNUS FY2021: $147.3MNUS FY2022: $104.8MNUS FY2023: $8.6MNUS FY2024: -$146.6MNUS FY2025: $160.2MFY18FY19FY20FY21FY22FY23FY24FY25FY26
MCK $4.8BNUS $160.2M
Net margin
MCK FY2019: 0.0%MCK FY2020: 0.4%MCK FY2021: -1.9%MCK FY2022: 0.4%MCK FY2023: 1.3%MCK FY2024: 1.0%MCK FY2025: 0.9%MCK FY2026: 1.2%NUS FY2018: 4.5%NUS FY2019: 7.2%NUS FY2020: 7.4%NUS FY2021: 5.5%NUS FY2022: 4.7%NUS FY2023: 0.4%NUS FY2024: -8.5%NUS FY2025: 10.8%FY18FY19FY20FY21FY22FY23FY24FY25FY26
MCK 1.2%NUS 10.8%
Revenue growth
MCK FY2020: +7.8%MCK FY2021: +3.1%MCK FY2022: +10.8%MCK FY2023: +4.8%MCK FY2024: +11.7%MCK FY2025: +16.2%MCK FY2026: +12.4%NUS FY2019: -9.7%NUS FY2020: +6.7%NUS FY2021: +4.4%NUS FY2022: -17.4%NUS FY2023: -11.5%NUS FY2024: -12.0%NUS FY2025: -14.3%FY19FY20FY21FY22FY23FY24FY25FY26
MCK +12.4%NUS -14.3%
Free cash flow
MCK FY2019: $3.6BMCK FY2020: $4BMCK FY2021: $4.1BMCK FY2022: $4BMCK FY2023: $4.8BMCK FY2024: $3.9BMCK FY2025: $5.5BMCK FY2026: $5.7BNUS FY2018: $132.4MNUS FY2019: $111.9MNUS FY2020: $315.3MNUS FY2021: $73MNUS FY2022: $49MNUS FY2023: $60.1MNUS FY2024: $70.2MNUS FY2025: $46MFY18FY19FY20FY21FY22FY23FY24FY25FY26
MCK $5.7BNUS $46M

Fiscal years as each company reports them; the two may end in different months.

Questions about McKesson and NU Skin Enterprises

Which is bigger by revenue, McKesson or NU Skin Enterprises?

McKesson is bigger by revenue: $403.4B in fiscal 2026, against $1.5B for NU Skin Enterprises in fiscal 2025.

Which keeps more of its revenue as profit, McKesson or NU Skin Enterprises?

McKesson had a net margin of 1.2% in fiscal 2026; NU Skin Enterprises had 10.8% in fiscal 2025.

Which grew revenue faster, McKesson or NU Skin Enterprises?

In their latest fiscal years revenue changed by +12.4% at McKesson and -14.3% at NU Skin Enterprises.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies